Key result
Hydrogen sulfide may serve as a potential alternative for managing myocardial fibrosis by mitigating oxidative stress, inflammation, and cellular death.
Why the study?
There is currently no targeted therapy for myocardial fibrosis, which is associated with many cardiovascular diseases and can lead to fatal heart failure.
Design
Review
Authors
Loading...
Premature for clinical use in myocardial fibrosis; leaves open therapeutic potential pending randomized human trials.
Hydrogen sulfide represents a potential novel therapeutic strategy for the management of myocardial fibrosis, a condition currently lacking targeted therapies.
Kang et al. (2020) conducted a review in Myocardial fibrosis. Hydrogen sulfide (H2S) was evaluated. Hydrogen sulfide may serve as a potential alternative for managing myocardial fibrosis by mitigating oxidative stress, inflammation, and cellular death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: